Sale!

KRIT1 Gene Cerebral Cavernous Malformations Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The KRIT1 Gene Cerebral Cavernous Malformations Type 1 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the KRIT1 gene. These mutations are responsible for Type 1 Cerebral Cavernous Malformations (CCM1), a condition characterized by the formation of abnormal blood vessels in the brain and spinal cord, which can lead to various neurological symptoms. The test is crucial for individuals with a family history of CCM1 or those exhibiting symptoms suggestive of the condition, as it helps in confirming the diagnosis, guiding treatment decisions, and assessing the risk for family members. The cost of the test is set at 4400 AED, reflecting the advanced genetic analysis involved in identifying the presence of mutations in the KRIT1 gene accurately. By opting for this test at DNA Labs UAE, patients and healthcare providers can access vital genetic information that plays a significant role in the management and understanding of Cerebral Cavernous Malformations.

Description

KRIT1 Gene Cerebral Cavernous Malformations Type 1 Genetic Test

Test Name: KRIT1 Gene Cerebral Cavernous Malformations Type 1 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Vascular Diseases

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for KRIT1 Gene Cerebral Cavernous Malformations Type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KRIT1 Gene Cerebral Cavernous Malformations Type 1 NGS Genetic DNA Test gene KRIT1

Test Details: The KRIT1 gene is associated with cerebral cavernous malformations type 1 (CCM1), a rare vascular disorder characterized by the formation of abnormal blood vessels in the brain and other organs. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of an individual’s genes. It allows for the simultaneous analysis of multiple genes, including the KRIT1 gene, to identify any genetic variations or mutations that may be causing or contributing to the development of cerebral cavernous malformations. NGS genetic testing for the KRIT1 gene can help diagnose individuals with suspected CCM1 and provide information about the specific genetic variant causing the condition. This information is valuable for understanding the inheritance pattern, predicting the risk of passing on the condition to future generations, and guiding appropriate medical management and genetic counseling.

Test Name	KRIT1 Gene Cerebral cavernous malformations type 1 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Vascular Diseases
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for KRIT1 Gene Cerebral cavernous malformations type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KRIT1 Gene Cerebral cavernous malformations type 1 NGS Genetic DNA Test gene KRIT1
Test Details	The KRIT1 gene is associated with cerebral cavernous malformations type 1 (CCM1), a rare vascular disorder characterized by the formation of abnormal blood vessels in the brain and other organs. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of an individual’s genes. It allows for the simultaneous analysis of multiple genes, including the KRIT1 gene, to identify any genetic variations or mutations that may be causing or contributing to the development of cerebral cavernous malformations. NGS genetic testing for the KRIT1 gene can help diagnose individuals with suspected CCM1 and provide information about the specific genetic variant causing the condition. This information is valuable for understanding the inheritance pattern, predicting the risk of passing on the condition to future generations, and guiding appropriate medical management and genetic counseling.